Moexipril hydrochloride, 98%, 1g

Methyl 2-((tert-butoxycarbonyl)amino)-2-(4-hydroxyphenyl)acetate, 95%, 500mg

6-(Hydroxymethyl)pyridin-3-ol, 95.0%, 250mg

6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine, 98%, 5mg

1-(4-Aminophenyl)pyrrolidin-3-ol, 95%, 100mg

1-(4-Chlorophenyl)-3-(1-methyl-1H-pyrazol-4-yl)propane-1,3-dione, 97.0%, 100mg

8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, 98%, 10g

(S)-1-Boc-2-Ethylpiperazine, 95.0%, 1g

Colonne HPLC NUCLEODUR® C18 Gravité 5 µm, 250 mm, 4,6 mm, 1 pièce(s)

4'-Cyano-[1,1'-biphenyl]-4-yl 4-(allyloxy)benzoate, 95%, 1g

Cobalt (II) oxalate dihydrate, 97.0%, 100g

5-METHYL-2,3-DIHYDROBENZO[B][1,4]DIOXINE-6-CARBOXYLIC ACID, 95.0%, 500mg

3-Chloro-2-(3-methoxyphenyl)pyridine, 98%, 250mg